N-trifluoroacetyladriamycin

26295-56-7

CAS-Nr.: 26295-56-7

Englisch Name:: N-trifluoroacetyladriamycin

Synonyma:: AD-41;NSC 283464;N-Trifluoroacetyldoxorubicin;(1S,3S)- α-2,3,6-trideoxy-3-(2,2,2-trifluoroacetaMido)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-Methoxy-6,11-dioxo-1-naphthacenyl L-lyxo-Hexopyranoside;(8S,10S)-7,8,9,10-Tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-[[3-(trifluoroacetylamino)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-6,8,11-trihydroxy-5,12-naphthacenedione;(8S-cis)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-Methoxy-10-[[2,3,6-trideoxy-3-[(trifluoroacetyl)aMino]-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-;2,2,2-Trifluoro-N-((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)acetamide (Doxorubicin Impurity)

CBNumber:: CB91398260

Summenformel:: C29H28F3NO12

Molgewicht:: 639.53

MOL-Datei:: 26295-56-7.mol

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 19

N-trifluoroacetyladriamycin Eigenschaften

Schmelzpunkt:: >150°C (dec.)

Siedepunkt:: 855.4±65.0 °C(Predicted)

Dichte: 1.66±0.1 g/cm3(Predicted)

Löslichkeit: DMSO, Methanol

pka: 7.35±0.60(Predicted)

Aggregatzustand: Solid

Farbe: Red

Sicherheit

Toxizität	dnd-hmn-lym 1 mg/L CNREA8 39,448,1979

N-trifluoroacetyladriamycin Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Red Solid

Verwenden

Doxorubicin (D558000) metabolite. Cytotoxic interaction with DNA.

Sicherheitsprofil

Mutation data reported. Whenheated to decomposition it emits toxic vapors of NOx andFí.

N-trifluoroacetyladriamycin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-trifluoroacetyladriamycin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 19)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Hubei Jusheng Technology Co.,Ltd.	18871490254	linda@hubeijusheng.com	CHINA	28180	58
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	19892	58
Hangzhou MolCore BioPharmatech Co.,Ltd.	+86-057181025280; +8617767106207	sales@molcore.com	China	49739	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11927	58
J & K SCIENTIFIC LTD.	010-82848833 400-666-7788	jkinfo@jkchemical.com	China	96815	76
Chemsky（shanghai）International Co.,Ltd.	021-50135380	shchemsky@sina.com	China	32344	50
BOC Sciences	16314854226	info@bocsci.com	United States	9926	65
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226 13028896684	sales@rrkchem.com	China	56070	58
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44843	58
Changzhou Bojia Biomedical Technology Co., Ltd.	2122619822	czbjpharma@126.com	China	18488	58

26295-56-7()Verwandte Suche:

Daunorubicin Doxorubicin

(8S,10S)-7,8,9,10-Tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-[[3-(trifluoroacetylamino)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-6,8,11-trihydroxy-5,12-naphthacenedione
AD-41
N-Trifluoroacetyldoxorubicin
(1S,3S)- α-2,3,6-trideoxy-3-(2,2,2-trifluoroacetaMido)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-Methoxy-6,11-dioxo-1-naphthacenyl L-lyxo-Hexopyranoside
(8S-cis)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-Methoxy-10-[[2,3,6-trideoxy-3-[(trifluoroacetyl)aMino]-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione
NSC 283464
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-
2,2,2-Trifluoro-N-((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)acetamide (Doxorubicin Impurity)
26295-56-7
C29H28F3NO12
Intermediates & Fine Chemicals
Pharmaceuticals